药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Betaprodine
Clostridium tetani toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Baricitinib.
Betaprodine
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Baricitinib.
Betaprodine
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Baricitinib.
Betaprodine
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Baricitinib.
Betaprodine
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Baricitinib.
Betaprodine
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Baricitinib.
Betaprodine
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Baricitinib.
Betaprodine
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Baricitinib.
Betaprodine
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Baricitinib.
Betaprodine
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Baricitinib.
Betaprodine
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Baricitinib.
Betaprodine
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Baricitinib.
Betaprodine
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Baricitinib.
Betaprodine
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Baricitinib.
Betaprodine
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Baricitinib.
Betaprodine
Tofacitinib
Baricitinib may increase the immunosuppressive activities of Tofacitinib.
Betaprodine
Favipiravir
The excretion of Baricitinib can be decreased when combined with Favipiravir.
Betaprodine
Pradigastat
The excretion of Baricitinib can be decreased when combined with Pradigastat.
Betaprodine
Edaravone
The excretion of Edaravone can be decreased when combined with Baricitinib.
Betaprodine
Ataluren
The excretion of Baricitinib can be decreased when combined with Ataluren.